1. Home
  2. NYT vs RDY Comparison

NYT vs RDY Comparison

Compare NYT & RDY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo New York Times Company (The)

NYT

New York Times Company (The)

HOLD

Current Price

$79.12

Market Cap

11.5B

ML Signal

HOLD

Logo Dr. Reddy's Laboratories Ltd

RDY

Dr. Reddy's Laboratories Ltd

HOLD

Current Price

$13.66

Market Cap

11.6B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
NYT
RDY
Founded
1851
1984
Country
United States
India
Employees
N/A
N/A
Industry
Newspapers/Magazines
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
11.5B
11.6B
IPO Year
1994
2001

Fundamental Metrics

Financial Performance
Metric
NYT
RDY
Price
$79.12
$13.66
Analyst Decision
Buy
Strong Buy
Analyst Count
7
1
Target Price
$72.14
$16.90
AVG Volume (30 Days)
1.8M
2.5M
Earning Date
05-06-2026
05-12-2026
Dividend Yield
1.16%
0.52%
EPS Growth
18.08
N/A
EPS
2.09
N/A
Revenue
$1,783,639,000.00
N/A
Revenue This Year
$10.58
$7.72
Revenue Next Year
$6.98
$3.50
P/E Ratio
$37.90
$18.67
Revenue Growth
N/A
N/A
52 Week Low
$51.03
$12.77
52 Week High
$87.10
$16.17

Technical Indicators

Market Signals
Indicator
NYT
RDY
Relative Strength Index (RSI) 45.46 52.46
Support Level $76.84 $12.90
Resistance Level $82.49 $13.96
Average True Range (ATR) 2.12 0.26
MACD -0.33 0.11
Stochastic Oscillator 52.76 61.89

Price Performance

Historical Comparison
NYT
RDY

About NYT New York Times Company (The)

New York Times Co is an American media company known for publishing its flagship newspaper, The New York Times. The company also operates the International New York Times newspaper, as well as digital properties such as NYTimes and various smartphone applications. The company has two segments: New York Times Group and The Athletic. The company generates the majority of its revenue from the NYTG segment. The NYTG and The Athletic segments derive revenue from subscriptions, Advertising, and others, where the majority source of revenue for both segments is subscription.

About RDY Dr. Reddy's Laboratories Ltd

Dr. Reddy's is one of the largest generic drug manufacturers in the world. It has a significant presence in North America, a region that makes up roughly half of its generics sales, and it services India (about 20% of its generics sales), Russia (10%), and certain European and Latin American countries. Beyond simple generics, Dr. Reddy's also has a solid portfolio of injectables which make up 25% of its North America sales. In branded generic markets like India, Dr. Reddy's has established a compelling presence with its strong brand name and earned a top five spot in key therapeutic areas including oncology and gastroenterology. Dr. Reddy's also has an active pharmaceutical ingredient business that manufactures over 150 APIs and sells in over 75 countries.

Share on Social Networks: